Hoffmann Eitle patent opposition analysis

The comprehensive analysis of Hoffmann Eitle opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Hoffmann Eitle

Patent NumberTitleApplicantOpposition DateOpposition Company
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKMay 6, 2026UNIVERSAL FARMA
Cellulose Carbamate PolymerINFINITED FIBERApr 16, 2026UPM KYMMENE
Process For Preparing A ResinSTORA ENSO OYJApr 7, 2026UPM KYMMENE
New SubstrateBILLERUD AKTIEBOLAG PUBLMar 25, 2026AHLSTROM OYJ
Individualized Vaccines For CancerTRON TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITTSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITT MAINZ GEMEINNTZIGEMar 24, 2026STRAWMAN
Automated HandTASKA PROSTHETICSMar 24, 2026OSSUR ICELAND EHF
Nasal Powder Formulation For Treatment Of HypoglycemiaELI LILLYMar 19, 2026STRAWMAN
Nasal Powder Formulation For Treatment Of HypoglycemiaELI LILLYMar 19, 2026STRAWMAN
Self-Propelled Press-CutterPRESSES ET CISAILLES LEFORTFeb 28, 2026LINDEMANN GERMANY
Cellulosic Textile FibreINFINITED FIBERFeb 20, 2026UPM KYMMENE